OPC,

I sold all shares prior to the dilution. I repurchased all shares after the dilution. I repurchased after the wash sale time requirement at $1.91 and as a result increased the number of shares held by 31%.

I am surprised by the recent rise in price per share. It is very difficult for me to determine the increased market size and timing due to the potential label expansion. The market acceptance may be a difficult matter and may take some time to penetrate. Despite approximately 5 times the number of shares available (after next additional dilution), the $5 2015 calls trade at double the cost of the 2014s when I sold them. Because I do not believe that the share price will be double, after an FDA approval, what it was planned to be (let's say approx $25/shr) prior to the dilution, I have not repurchased options. I need to understand the share price potential before digging in deeper. Right now I'm having difficulty determining that answer.

WDNering